Claims
- 1. A method for the treatment of hypertension in a mammal in need thereof which comprises administering to said mammal a therapeutically effective antihypertensive amount of N-acetyl-serotonin (NAS) or a pharmaceutically acceptable salt thereof.
- 2. The method of claim 1, wherein the mammal is a human.
- 3. The method of claim 1, wherein said NAS is administered by the oral route.
- 4. The method of claim 1, wherein said NAS is administered together with an acceptable carrier therefor.
- 5. The method of claim 1, wherein said NAS is administered in the form of an orally ingestible capsule or tablet.
- 6. The method of claim 1, wherein said NAS is administered in combination with S-adenosylhomocysteine.
Parent Case Info
This application claims the benefit of U.S. Provisional Application Ser. No. 60/042,665, filed Apr. 4, 1997, and is a continuation of PCT/US98/04909, filed Mar. 12, 1998.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
4600723 |
Short et al. |
Jul 1986 |
|
Non-Patent Literature Citations (2)
Entry |
Chemical Abstract 96:15483, "Hypotensive Effect of Melatonin in Essential Hypertension" Oct. 1981. |
Database CA on STN, Assession No. 106:27721, Oxenkrug, et al., Sch. Med. Wayne State University, Abstract to J. Neural Transm 1986, vol. 66, No. 3-4, pp. 271-281. |
Continuations (1)
|
Number |
Date |
Country |
Parent |
PCTUS9804909 |
Mar 1998 |
|